United States News Todas as matérias

Xtant Medical Holdings (NYSE:XTNT) announced on April 13, 2026, that it has secured exclusive U.S. distribution rights for HEMOBLAST Bellows, a specialized hemostatic powder developed by Dilon Technologies.

Kymera Therapeutics (NASDAQ:KYMR) received U.S. Food and Drug Administration Fast Track designation for its experimental treatment for moderate-to-severe eosinophilic asthma, a move that could accelerate the path to market for the first-in-class oral therapy.

Aeluma (NASDAQ:ALMU), a pioneer in the development of high-performance optoelectronic devices, announced on April 13, 2026, that it has been awarded more than $4 million in new U.S. government contracts.

Perella Weinberg Partners (NASDAQ:PWP) has entered into a definitive agreement to acquire Gleacher Shacklock, a prominent London-based independent advisory firm.

Lazard (NYSE:LAZ) reported preliminary assets under management (AUM) of approximately $259.2 billion as of March 31, 2026.

Eli Lilly and Company (NYSE:LLY) announced Monday that its Phase 3 BRUIN CLL-322 trial achieved its primary endpoint, demonstrating that the addition of Jaypirca (pirtobrutinib) to a standard regimen of venetoclax and rituximab significantly extended the time patients lived without their disease worsening.

Somnigroup International (NYSE:SGI) reached an agreement to acquire Leggett & Platt (NYSE:LEG) in an all-stock transaction valued at approximately $2.5 billion, a move that unites the world's largest bedding brand owner with its primary component supplier.

Fastenal (NASDAQ:FAST), a global leader in the wholesale distribution of industrial and construction supplies, reported its financial results for the first quarter ended March 31, 2026, today.

Vertiv Holdings (NYSE:VRT), a global provider of critical digital infrastructure and continuity solutions, announced on April 13, 2026, the acquisition of BMarko Structures.

Regeneron Pharmaceuticals (NASDAQ:REGN) and Telix Pharmaceuticals (NASDAQ:TLX) announced a landmark strategic collaboration on April 13, 2026, to co-develop and co-commercialize next-generation radiopharmaceutical therapies (RPTs).

Hillman Solutions (NASDAQ:HLMN), a leading provider of hardware products and merchandising solutions, announced on April 13, 2026, the acquisition of Delaney Hardware.

Allogene Therapeutics (NASDAQ:ALLO), a pioneer in allogeneic "off-the-shelf" CAR-T cell therapy, announced promising interim futility results today from its randomized Phase 2 ALPHA3 trial.

Regeneron Pharmaceuticals (NASDAQ:REGN) and Sanofi (NASDAQ:SNY) announced on April 13, 2026, that the European Commission, has expanded the marketing authorization for Dupixent (dupilumab) to include children aged 2 to 11 years with moderate-to-severe chronic spontaneous urticaria (CSU).

Baker Hughes (NASDAQ:BKR), a global leader in energy technology, announced on April 13, 2026, that it has reached a definitive agreement to sell its Waygate Technologies business to Hexagon, a Swedish-based leader in digital reality solutions.

AbbVie (NYSE:ABBV) and Haisco Pharmaceutical Group announced on April 10, 2026, a strategic licensing agreement to develop and commercialize a portfolio of novel pain compounds.

Borr Drilling (NYSE:BORR) issued a comprehensive operational update on April 13, 2026, announcing the return of four high-specification jack-up rigs to service in the Middle East.

ADS-TEC Energy (NASDAQ:ADSE), a global leader in battery-buffered ultra-fast charging technology, released its preliminary and unaudited financial statements for the fiscal year 2025 today.

High-stakes talks between the United States and Iran in Islamabad ended without an agreement after 21 hours of negotiations, marking another setback in efforts to ease regional tensions.

Robin Energy (NASDAQ:RBNE), an international ship-owning company specializing in energy transportation, reported a significant surge in revenue for the fourth quarter of 2025 on April 10, 2026.

LifeMD (NASDAQ:LFMD), a leader in virtual primary care, announced on April 10, 2026, the addition of Eli Lilly’s newly approved oral weight-loss medication, Foundayo (orforglipron), to its comprehensive weight management program.

Invesco (NYSE:IVZ) reported on April 10, 2026, that its preliminary month-end assets under management (AUM) reached $2,159.5 billion as of March 31.

Pony.ai (NASDAQ:PONY), a global leader in autonomous driving technology, announced on April 10, 2026, the official launch of PonyWorld 2.0.

HomesToLife (NASDAQ:HTLM), a regional furniture retailer and manufacturer, announced today that its shareholders have formally approved a final special cash dividend of US$0.065 per ordinary share.

Braiin (NASDAQ:BRAI), a global provider of integrated industrial technology and AI-driven agricultural solutions, announced on April 10, 2026, that its Board of Directors and shareholders have approved a three-for-one forward stock split.